It is seen to be of low biologic thyroid hormone activity (44) as a T4-like agent in terms of nuclear receptor-mediated effects, but a large number of reports have documented in preclinical studies its anticancer activity mediated by the thyroid hormone analogue receptor on cancer cell plasma membrane integrin αvβ3 (3). Here, TG is linked to cancer.